Surefire Medical out of Westminster, CO received European clearance to market its eponymous Surefire Infusion System for use in for chemo- and radioembolization procedures. The system is designed to offer a more consistent embolization option over traditional microcatheters.
According to the company, a clinical study of the Surefire demonstrated no visible (under angiography) reflux nor any evidence of embolization of tissue not explicitly targeted by the physician. The system has been approved in the U.S. since the Summer of last year.
From the product page:
Surefire’s infusion catheters—which precisely deliver embolic agents through a novel expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow—are designed to increase infusion efficiency and minimize reflux.
Press release: SUREFIRE MEDICAL’S INFUSION SYSTEM RECEIVES CE MARK APPROVAL
Product page and video: Surefire Infusion System